Delivery Order SPE2DB20D1109-SPE2DB25FP83F
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,864.76 for 100 tablets of Nucynta 75 mg on June 2, 2025, with completion scheduled for June 3, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a specific pharmaceutical delivery under DLA's medical supply chain operations, with performance to occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,789.57 for 100 tablets of Nucynta 75 mg on September 2, 2025, with completion targeted for September 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,225.04 to AmerisourceBergen Drug Corp for 100 tablets of Nucynta 50 mg, a pain management pharmaceutical. This competitive delivery order, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, utilizes firm fixed pricing and carries no set-aside designation. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $13,932.13 for Nucynta Tabs 75mg, a pain management pharmaceutical product. This firm fixed-price delivery order, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a competitive procurement with no set-aside designation. The award is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Nucynta 75 mg tablets (100 count) with a ceiling value of $2,451.24. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta 75 mg tablets (100 count) on September 25, 2025, with a contract ceiling value of $4,482.56. This delivery order represents a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 26, 2025. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for supply of Nucynta 75 mg tablets (100 count) valued at $1,432.38 under a firm fixed price contract. The award, issued on July 30, 2025, with a completion date of July 31, 2025, represents a small-value pharmaceutical procurement with no set-aside designation. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Nucynta 75 mg tablets (100-count units) valued at $30,223.35. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a non-competitive award to the pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Nucynta 50 mg tablets (100 count) with a ceiling value of $1,225.04. This firm fixed-price delivery order, with an ultimate completion date of July 23, 2025, represents a direct fulfillment of pharmaceutical needs through the federal medical supply chain. The contract is not set-aside and was competitively awarded, reflecting AmerisourceBergen's established capability as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,899.74 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract action under...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP83FDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,764.50 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Nucynta 75 mg tablets (100 count). This firm fixed-price delivery order, with an ultimate completion date of September 26, 2025, represents a pediatric pain management pharmaceutical product for military healthcare needs. The award was made through open competition with no set-aside designation, and the product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The underlying IDC demonstrates AmerisourceBergen's substantial capacity as a major pharmaceutical distributor for federal medical procurement, with this particular delivery order exemplifying the routine pharmaceutical supply missions executed under that larger contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 9/25/25 |